Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection

Journal of Animal Science

Volumn 84, Issue 3, 2006, Pages 733-742

  Thacker, E L ^a   Holtkamp, D J ^b   Khan, A S ^b   Brown, P A ^b   Draghia Akli, R ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b ADViSYS Inc   (United States)

Author keywords

Insulin like growth factor I; Pig; Plasmid; Somatoliberin; Vaccination

Indexed keywords

ANIMALIA; ARTERIVIRUS; MYCOPLASMA; MYCOPLASMA HYOPNEUMONIAE; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS SCROFA;

EID: 33646166860     PISSN: 00218812     EISSN: None     Source Type: Journal    
DOI: 10.2527/2006.843733x     Document Type: Article

References (40)

1. Abrahamsen, B., T. L. Nielsen, J. Hangaard, G. Gregersen, N. Vahl, L. Korsholm, T. B. Hansen, M. Andersen, and C. Hagen. 2004. Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency. Eur. J. Endocrinol. 150:671-679.
2. Amanfu, W., C. N. Weng, R. F. Ross, and H. J. Barnes. 1984. Diagnosis of mycoplasmal pneumonia of swine: Sequential study by direct immunofluorescence. Am. J. Vet. Research 45:1349-1352.
3. Bereiter, M., T. F. Young, H. S. Joo, and R. F. Ross. 1990. Evaluation of the ELISA and comparison to the complement fixation test and radial immunodiffusion enzyme assay for detection of antibodies against Mycoplasma hyopneumoniae in swine serum. Vet. Microbiol. 25:177-192.
4. Bozzola, M., F. De Benedetti, M. De Amici, B. Jouret, P. Travaglino, S. Pagani, F. Conte, and M. Tauber. 2003. Stimulating effect of growth hormone on cytokine release in children. Eur. J. Endocrinol. 149:397-401.
5. Brown, P. A., W. C. Davis, and R. Draghia-Akli. 2004. Immune enhancing effects of growth hormone releasing hormone delivered by plasmid injection and electroporation. Mol. Ther. 10:644-651.
6. Burgess, W., Q. Liu, J. Zhou, Q. Tang, A. Ozawa, R. VanHoy, S. Arkins, R. Dantzer, and K. W. Kelley. 1999. The immune-endocrine loop during aging: Role of growth hormone and insulin-like growth factor-I. Neuroimmunomodulation. 6:56-68.
7. Dialynas, E., H. Brown-Borg, and A. Bartke. 1999. Immune function in transgenic mice overexpressing growth hormone (GH) releasing hormone, GH or GH antagonist. Proc. Soc. Exp. Biol. Med. 221:178-183.
8. Dorshkind, K., and N. D. Horseman. 2001. Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23:288-294.
9. Draghia-Akli, R., K. M. Ellis, L. A. Hill, P. B. Malone, and M. L. Fiorotto. 2003. High-efficiency growth hormone releasing hormone plasmid vector administration into skeletal muscle mediated by electroporation in pigs. FASEB J 17:526-528.
10. Draghia-Akli, R., and M. L. Fiorotto. 2004. A new plasmid-mediated approach to supplement somatotropin production in pigs. J. Anim. Sci. 82:E264-E269.
11. Draghia-Akli, R., M. L. Fiorotto, L. A. Hill, P. B. Malone, D. R. Deaver, and R. J. Schwartz. 1999. Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs. Nat. Biotechnol. 17:1179-1183.
12. Draghia-Akli, R., A. S. Khan, K. K. Cummings, D. Parghi, R. H. Carpenter, and P. A. Brown. 2002. Electrical Enhancement of Formulated Plasmid Delivery in Animals. Technol. Cancer Res. Treat. 1:365-371.
13. Evans, W. S., M. L. Vance, D. L. Kaiser, R. P. Sellers, J. L. Borges, T. R. Downs, L. A. Frohman, J. Rivier, W. Vale, and M. O. Thorner. 1985. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men. J. Clin. Endocrinol. Metab. 61:846-850.
14. Gelato, M. C. 1996. Aging and immune function: A possible role for growth hormone. Horm. Res. 45:46-49.
15. Halbur, P. G., P. S. Paul, M. L. Frey, J. Landgraf, K. Eernisse, X. J. Meng, M. A. Lum, J. J. Andrews, and J. A. Rathje. 1995. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet. Pathol. 32:648-660.
16. Hammerschlag, M. R. 2001. Mycoplasma pneumoniae infections. Curr. Opin. Infect. Dis. 14:181-186.
17. Khorram, O., M. Garthwaite, and T. Golos. 2001. The influence of aging and sex hormones on expression of growth hormone-releasing hormone in the human immune system. J. Clin. Endocrinol. Metab. 86:3157-3161.
18. Khorram, O., M. Yeung, L. Vu, and S. S. Yen. 1997. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women. J Clin. Endocrinol. Metab. 82:3590-3596.
19. Kobashi, Y., N. Okimoto, T. Matsushima, and R. Soejima. 2001. Clinical analysis of community-acquired pneumonia in the elderly. Intern. Med. 40:703-707.
20. Koo, G. C., C. Huang, R. Camacho, C. Trainor, J. T. Blake, A. Sirotina-Meisher, K. D. Schleim, T. J. Wu, K. Cheng, R. Nargund, and G. McKissick. 2001. Immune enhancing effect of a growth hormone secretagogue. J. Immunol. 166:4195-4201.
21. Krieg, A. M. 1999. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim. Biophys. Acta 1489:107-116.
22. Krishnaraj, R., A. Zaks, and T. Unterman. 1998. Relationship between plasma IGF-I levels, in vitro correlates of immunity, and human senescence. Clin. Immunol. Immunopathol. 88:264-270.
23. Li, X., E. M. Eastman, R. J. Schwartz, and R. Draghia-Akli. 1999. Synthetic muscle promoters: Activities exceeding naturally occurring regulatory sequences. Nat. Biotechnol. 17:241-245.
24. Maes, D., M. Verdonck, H. Deluyker, and A. de Kruif. 1996. Enzootic pneumonia in pigs. Vet. Q. 18:104-109.
25. Marshall, L., B. Perras, H. L. Fehm, and J. Born. 2001. Changes in immune cell counts and interleukin (IL)-1beta production in humans after a somnogenically active growth hormone-releasing hormone (GHRH) administration. Brain Behav. Immun. 15:227-234.
26. Mengeling, W. L., K. M. Lager, and A. C. Vorwald. 1995. Diagnosis of porcine reproductive and respiratory syndrome. J. Vet. Diagn. Invest. 7:3-16.
27. Muramatsu, T., S. Arakawa, K. Fukazawa, Y. Fujiwara, T. Yoshida, R. Sasaki, S. Masuda, and H. M. Park. 2001. In vivo gene electroporation in skeletal muscle with special reference to the duration of gene expression. Int. J. Mol. Med. 7:37-42.
28. Sakai, M., Y. Kajita, M. Kobayashi, and H. Kawauchi. 1997. Immunostimulating effect of growth hormone: In-vivo administration of growth hormone in rainbow trout enhances resistance to Vibrio anguillarum infection. Vet. Immunol. Immunopathol. 57:147-152.
29. Sarradell, J., M. Andrada, A. S. Ramirez, A. Fernandez, J. C. Gomez-Villamandos, A. Jover, H. Lorenzo, P. Herraez, and F. Rodriguez. 2003. A morphologic and immunohistochemical study of the bronchus-associated lymphoid tissue of pigs naturally infected with Mycoplasma hyopneumoniae. Vet. Pathol. 40:395-404.
30. Siejka, A., H. Lawnicka, J. Komorowski, T. Stepien, R. Krupinski, and H. Stepien. 2004. Effect of growth hormone-releasing hormone (GHRH) and GHRH antagonist (MZ-4-71) on interferon-gamma secretion from human peripheral blood mononuclear cells in vitro. Neuropeptides 38:35-39.
31. Steinman, L. 2004. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5:575-581.
32. Stipkovits, L., J. Nicolet, A. Haldimann, and J. Frey. 1991. Use of antibodies against the P36 protein of Mycoplasma hyopneumoniae for the identification of M. hyopneumoniae strains. Mol. Cell Probes 5:451-457.
33. Thacker, E. L., P. G. Halbur, R. F. Ross, R. Thanawongnuwech, and B. J. Thacker. 1999. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. J. Clin. Microbiol. 37:620-627.
34. Thacker, E. L., B. J. Thacker, T. B. Boettcher, and H. Jayappa. 1998. Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins. Swine Health and Production 6:107-112.
35. Thacker, E. L., B. J. Thacker, M. Kuhn, P. A. Hawkins, and W. R. Waters. 2000a. Mucosal and systemic characteristics of protective activity of a Mycoplasma hyopneumoniae bacterin. Am. J. Vet. Res. 61:1384-1389.
36. Thacker, E. L., B. J. Thacker, T. F. Young, and P. G. Halbur. 2000b. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae. Vaccine 18:1244-1252.
37. Thibodeau, K. P., and A. J. Viera. 2004. Atypical pathogens and challenges in community-acquired pneumonia. Am. Fam. Physician 69:1699-1706.
38. Thorner, M. O., M. L. Vance, W. S. Evans, A. D. Rogol, J. Rivier, W. Vale, and R. M. Blizzard. 1986. Clinical studies with GHRH in man. Horm. Res. 24:91-98.
39. Tone, C. M., D. M. Cardoza, R. H. Carpenter, and R. Draghia-Akli. 2004. Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs. Cancer Gene Ther. 11:389-396.
40. Van den, B. G. 2003. Endocrine evaluation of patients with critical illness. Endocrinol. Metab. Clin. North Am. 32:385-410.